News

A clinical trial is planned to see if a single injection of progenitor cells can help repair spinal cords inflamed by transverse myelitis.

Researchers have uncovered a brain-signaling pathway that can be altered in genetically engineered mice to reverse an autism-related pathway. Using a drug targeting this pathway, the researchers normalized disrupted physiology and behavior in these mice. The results suggest a possible route to medication development for adults with autism spectrum disorder.

In the rodent form of type 1 diabetes, specific immune cells fail to respond to one of these checkpoint molecules, letting the immune system go into overdrive and attack insulin-producing cells.

Results are out from the world’s first gene therapy trial for a genetic cause of blindness, known as choroideremia.

A special imaging technique has shown how membrane proteins change their structure when they move molecules out of the cell.

Medical University of South Carolina (MUSC) neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of using brain surgery to treat debilitating seizures caused by epilepsy.

A new computational approach that allows the identification of molecular alterations associated with prognosis and resistance to therapy of different types of cancer has been developed at the Instituto de Medicina Molecular João Lobo Antunes.

Penn State researchers are the first to use data obtained from recent next-generation satellites in a numerical weather-prediction model used to provide guidance for tornadic thunderstorm forecasting.

The results of the first scientific experiments at Europe's new X-ray laser European XFEL reveals a previously unknown structure of an enzyme responsible for antibiotic resistance.

Unexpected enzyme structure holds promise for removal of greenhouse gases from the atmosphere to turn them into useful carbon-containing compounds.